ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Business trends

Pharmaceutical maker Shionogi tapping AI to speed drug development

Partnership with IT giant Accenture is expected to reduce costs, improve outcomes

Japanese pharmaceutical maker Shionogi wants to speed drug development and reduce costs.

TOKYO -- In an unorthodox move for a Japanese pharmaceutical company, Shionogi & Co. has begun to foster personnel with information technology skills for new drug development.

IT specialists are fairly rare in the drug sector, and Shionogi Director and Senior Executive Officer Takuko Sawada readily admits that her company has also been late to digitize its drug discovery efforts.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more